In addition, the protein also affects the activity of key signaling pathways, such as NF-κB and Keap1/Nrf2/HO-1, further alleviating IBD symptoms by inhibiting inflammatory responses and enhancing antioxidant capacity (Figure 1). Here, NFKB1 is linked to inflammatory bowel disease.